Therapy of candidal vaginitis: The effect of eliminating intestinal Candida

  • Nystatin Multicenter Study Group
      This paper is only available as a PDF. To read, Please Download here.


      A total of 258 patients with candidal vulvovaginitis, all of whom also exhibited Candida organisms in the rectum, were treated for 1 week with vaginal tablets only (nystatin or clotrimazole) or with both vaginal and oral tablets (nystatin). Mycologic and symptomatic responses were superior for the group receiving combined intravaginal-oral therapy; the vaginas of 88% of those treated by both routes were cleared of Candida, as compared with 75% of those receiving only intravaginal medication (p < 0.05). Nystatin and clotrimazole were equally effective. When the 258 patients, regardless of treatment regimen, were grouped into those whose intestinal tracts after therapy contained Candida or those free of Candida, the response rates of the vaginal infection at all follow-up examinations favored the latter group (p < 0.05 to < 0.001). Vaginal infection recurred in 19.7% of patients treated only intravaginally and 14.7% of those receiving combined therapy. These results suggest the value of eliminating any intestinal reservoir of Candida when treating patients with candidal vulvovaginitis.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Miles MR
        • Olsen L
        • Rogers A
        Recurrent vaginal candidiasis.
        JAMA. 1977; 238: 1836-1837
        • Hilton AL
        • Warnock DW
        Vaginal candidiasis and the role of the digestive tract as a source of infection.
        Br J Obstet Gynaecol. 1975; 82: 922-926
        • Rohatiner JJ
        Relationship of Candida albicans in the genital and anorectal tracts.
        Br J Vener Dis. 1966; 42: 197-200
        • de Sousa HM
        • Uden N.van
        The mode of infection and reinfection in yeast vulvovaginitis.
        Am J Obstet Gynecol. 1960; 80: 1096-1100
        • Velupillai S
        • Thin RN
        Treatment of vulvovaginal yeast infection with nystatin.
        Practitioner. 1977; 219: 897-901
        • Milne JD
        • Warnock DW
        Effect of simultaneous oral and vaginal treatment of the rate of cure and relapse in vaginal candidosis.
        Br J Vener Dis. 1979; 55: 362-365
        • Tan CG
        • Milne LJR
        • Good CS
        • Loudon JDO
        A comparative trial of six day therapy with clotrimazole and nystatin in pregnant patients with vaginal candidiasis.
        Postgrad Med J. 1974; 50: 102-105
        • Higton BK
        A trial of clotrimazole and nystatin in vaginal candidiasis.
        Postgrad Med J. 1974; 50: 95-97
        • Masterton G
        • Henderson J
        • Napier IR
        • Moffet M
        Six-day clotrimazole therapy in vaginal candidosis.
        Curr Med Res Opin. 1975; 3: 83-88
        • Marks HJ
        A double-blind comparison of clotrimazole and nystatin vaginal tablets in candida vaginitis.
        Postgrad Med J. 1974; 50: 105-108
        • Eliot BW
        • Howat RCL
        • Mack AE
        A comparison between the effects of nystatin, clotrimazole and miconazole on vaginal candidiasis.
        Br J Obstet Gynaecol. 1979; 86: 572-577
        • Svendsen E
        • Lie S
        • Gunderson TH
        • Lyngstad-Vik I
        • Skuland J
        Comparative evaluation of miconazole, clotrimazole and nystatin in the treatment of candidal vulvo-vaginitis.
        Curr Ther Res. 1978; 23: 666-672
        • Cartwright RY
        Clotrimazole in the treatment of acute and ‘resistant’ vaginal candidiasis.
        Postgrad Med J. 1974; 50 (1974): 90-92
        • Fleiss JL
        Statistical methods for rates and proportions.
        John Wiley & Sons, New York1973
        • Lebherz TB
        • Goldman L
        • Wiesmeier E
        • Mason D
        • Ford LC
        A comparison of the efficacy of two vaginal creams for vulvovaginal candidiasis, and correlations with the presence of Candida species in the perianal area and oral contraceptive use.
        Clin Ther. 1983; 5: 409-416
        • Bishop YMM
        • Fienberg SE
        • Holland PW
        Discrete multivariate analysis theory and practice.
        MIT Press, Cambridge, Massachusetts1975
        • Lambotte R
        • Dogniez B
        • Sandront-Degee M
        Influence of rectal infections caused by Candida albicans on the therapeutic results obtained in vaginal candidosis.
        Mykosen. 1978; 21: 311-313
        • Anyon CP
        • Desmond FB
        • Eastcott DF
        A study of Candida in one thousand and seven women.
        NZ Med J. 1971; 73: 9-13